Literature DB >> 26051093

Mild ovarian stimulation with clomiphene citrate launch is a realistic option for in vitro fertilization.

Anna Pia Ferraretti1, Luca Gianaroli2, Maria Cristina Magli2, Paul Devroey2.   

Abstract

OBJECTIVE: To validate the use of clomiphene citrate in IVF when mild stimulation approaches are chosen to reduce patient discomfort, risk, and cost.
DESIGN: Prospective cohort study.
SETTING: Private IVF clinic. PATIENT(S): A total of 163 patients undergoing IVF and with a good prognosis (defined as ≤38 years old with normal ovarian reserve and normovulatory cycles, body mass index <29 kg/m(2), no previous assisted reproductive technology cycles, no severe endometriosis, no history of recurrent miscarriage, no endocrine/autoimmune diseases, and no surgical semen extraction). INTERVENTION(S): Mild stimulation using a fixed protocol of clomiphene citrate (100 mg/d from cycle days 3 to 7) in combination with low doses of gonadotropins (150 IU of recombinant FSH on cycle days 5, 7, and 9) and GnRH antagonist. MAIN OUTCOME MEASURE(S): The cumulative delivery rate per patient after three fresh and/or frozen embryo transfers and time to pregnancy. RESULT(S): No dropouts were observed. The cumulative delivery rate was 70%, and the mean time to pregnancy was 2.4 months. CONCLUSION(S): Mild stimulation using clomiphene citrate in combination with low doses of gonadotropins can be considered a realistic option for good-prognosis patients undergoing IVF.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IVF; Mild stimulation; clomiphene citrate; dropout

Mesh:

Substances:

Year:  2015        PMID: 26051093     DOI: 10.1016/j.fertnstert.2015.05.006

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Clinical efficiency of Piezo-ICSI using micropipettes with a wall thickness of 0.625 μm.

Authors:  Kenichiro Hiraoka; Seiji Kitamura
Journal:  J Assist Reprod Genet       Date:  2015-10-21       Impact factor: 3.412

2.  New Generation IVF - What does it mean?

Authors:  Wim Ombelet
Journal:  Facts Views Vis Obgyn       Date:  2015-12-28

3.  IVF in Africa: what is it all about?

Authors:  W Ombelet; J Onofre
Journal:  Facts Views Vis Obgyn       Date:  2019-03

Review 4.  Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective.

Authors:  Padma Rekha Jirge; Madhuri Milind Patil; Rohit Gutgutia; Jatin Shah; Mridubhashini Govindarajan; Varsha Samson Roy; Nalini Kaul-Mahajan; Faddy I Sharara
Journal:  J Hum Reprod Sci       Date:  2022-06-30

5.  Serum Biopterin and Neopterin Levels as Predictors of Empty Follicles.

Authors:  Akihiro Hamuro; Daisuke Tachibana; Takuya Misugi; Hiroko Katayama; Koji Ozaki; Yuji Fujino; Nakamura Yoshihiro; Haruo Shintaku; Masayasu Koyama
Journal:  Jpn Clin Med       Date:  2015-11-02

6.  Minimal Stimulation In Vitro Fertilization: A Better Outcome.

Authors:  Adrija Kumar Datta
Journal:  Int J Fertil Steril       Date:  2016-06-01

7.  Global reproductive health - Why do we persist in neglecting the undeniable problem of childlessness in resource-poor countries?

Authors:  W Ombelet; J Goossens
Journal:  Facts Views Vis Obgyn       Date:  2017-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.